Wellgistics Health, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a WGRX research report →
About the company
Wellgistics Health, Inc. functions as a primary wholesaler and distributor of pharmaceutical products throughout the United States, catering to both drug manufacturers and independent retail pharmacies. Its extensive product catalog includes a variety of generic and brand-name pharmaceuticals, alongside over-the-counter healthcare and consumer merchandise.
- CEO
- Prashant Patel
- IPO
- 2025
- Employees
- 31
- HQ
- Tampa, FL, US
Price Chart
- Market Cap
- $7.49M
- P/E
- -0.07
- P/S
- 0.53
- P/B
- -0.28
- EV/EBITDA
- -0.67
- Div Yield
- 0.00%
- Gross Margin
- -69.22%
- Op Margin
- -398.05%
- Net Margin
- -545.72%
- ROE
- 1545.09%
- ROIC
- -403.31%
- Revenue
- $23.34M · 28.73%
- Net Income
- $-101,274,530 · -1377.12%
- EPS
- $-71.50 · -1000.00%
- Op Income
- $-81,194,831
- FCF YoY
- -577.47%
- 52W High
- $97.50
- 52W Low
- $2.81
- 50D MA
- $4.46
- 200D MA
- $18.23
- Beta
- -1.46
- Avg Volume
- 745.01K
Get TickerSpark's AI analysis on WGRX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 22, 26 | AJJARAPU SURENDRA K | other | 100,000 |
| Jun 22, 26 | AJJARAPU SURENDRA K | other | 100,000 |
| Jun 22, 26 | Patel Prashant | other | 100,000 |
| Jun 22, 26 | Patel Prashant | other | 100,000 |
| Mar 31, 26 | Patel Prashant | other | 5,000,000 |
| Mar 31, 26 | AJJARAPU SURENDRA K | other | 5,000,000 |
| Mar 31, 26 | Patel Prashant | other | 5,000,000 |
| Mar 31, 26 | Patel Prashant | other | 5,000,000 |
| Mar 31, 26 | AJJARAPU SURENDRA K | other | 5,000,000 |
| Mar 31, 26 | AJJARAPU SURENDRA K | other | 5,000,000 |
Our WGRX coverage
Recent articles, reports, and earnings notes.
No research on WGRX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate WGRX report →Similar companies
Peers in the same neighborhood.